DentalMonitoring has secured De Novo approval from the US Food and Drug Administration (FDA) for its AI-powered remote orthodontic monitoring solution.

The authorisation allows orthodontists to utilise the DentalMonitoring medical device software to enhance clinical care.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The software employs advanced image processing algorithms to assess oral cavity images that are taken using the DM App, a smartphone, and the manufacturer’s hardware products.

DentalMonitoring’s software is designed to assist healthcare professionals in remotely tracking dental treatments, orthodontic treatments, oral health, and treatment progress.

The solution is indicated for patients above six and focuses on permanent teeth. It is intended to be used as a diagnostic aid rather than a standalone tool for clinical decision-making.

DentalMonitoring CEO and co-founder Philippe Salah said: “FDA approval of this improved version of DentalMonitoring software is a key milestone for DentalMonitoring and marks the beginning of a new era in orthodontics.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The technology offers an additional layer of information beyond traditional orthodontic treatment follow-ups, ensuring patient adherence to treatment requirements. Clinicians gain a deeper understanding of treatment progress while patients benefit from the convenience of remote monitoring.

It also offers automated notifications and in-app communication with practice staff to improve patient engagement and foster better communication between healthcare providers, patients and caregivers.

DentalMonitoring is also introducing SmartSTL to its orthodontist customers in North America.

This feature allows doctors to request updated STL files directly from the DentalMonitoring dashboard, eliminating the need for patients to return to the office.

Last year, DentalMonitoring launched ScanAssist, an AI-guided scan for orthodontics.

The device helps patients complete their scans while aiming to provide a fun and engaging patient experience.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact